Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Timing and Specificity of the Cognitive Changes Induced by Interleukin-2 and Interferon-α Treatments in Cancer Patients

Bibliographic Data

ID19303917
AuthorsLucile Capuron (0000-0002-2060-5918, Inserm), Alain Ravaud (0000-0001-9455-6744), Robert Dantzer (0000-0001-9399-6107)
Year2001
Volume63
Issue3
Pages376-386
Publication date2001-05-01
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenuePsychosomatic Medicine (JOURNAL)
Journal identifiersISSN: 0033-3174 • E-ISSN: 1534-7796
PublisherOvid Technologies (Wolters Kluwer Health) (PUBLISHER)
DOI10.1097/00006842-200105000-00007
PMID11382265
OpenAlexW2005149888
LanguageEN
Citations received3
References cited43

OBJECTIVE: Neuropsychological changes develop in patients treated by cytokine immunotherapy with interleukin-2 (IL-2) and interferon-alpha (IFN-alpha). However, the time course of appearance of these effects remains unclear, and their precise nature is still incompletely characterized. The objective of this study was to assess and characterize the early cognitive changes induced by IL-2 and IFN-alpha in cancer patients at the end of the first week of treatment and to investigate the subsequent evolution of these changes. METHODS: The study was conducted in 47 cancer patients who received subcutaneous IL-2, administered alone (N = 17) or with IFN-alpha (N = 7), or IFN-alpha alone, administered subcutaneously at low doses (N = 7) or intravenously at high doses (N = 16). An automated battery of neuropsychological tests (Cambridge Neuropsychological Test Automated Battery) was used to measure reaction time, spatial working memory, and planning tasks. Cognitive tests were performed before treatment (day 1) and after 5 days (day 5) and 1 month of treatment. RESULTS: On day 5, patients treated with IL-2 alone had impaired spatial working memory and lower accuracy of planning abilities. In contrast, patients treated with IFN-alpha did not show any impairment in performance accuracy in these tasks but showed longer latencies in the test of reaction time. Most of these early alterations persisted at the end of the first month of treatment without any obvious sign of worsening. CONCLUSIONS: These findings suggest the existence of early differential neuropsychological changes in patients treated with IL-2 and IFN-alpha

Alpha (finance) · Alpha interferon · Cancer · Cognition · Cytokine · Immunotherapy · Interferon · Neuropsychological test · Neuropsychology · Psychiatry · Psychometrics · Cancer-related cognitive impairment studies · Clinical Psychology · Immunology · Intensive Care Unit Cognitive Disorders · Internal Medicine · Medicine · Oncology · Tryptophan and brain disorders

  • An Evolutionary Hypothesis of Suicide

    Open Access•Midori Tanaka, Dennis K Kinney•Psychological Reports•2011

  • An exposome connectivity paradigm for the mechanistic assessment of the effects of prenatal and early life exposure to metals on neurodevelopment

    Open Access•Ourania Anesti, Nafsika Papaioannou et al.•Frontiers in Public Health•2023

  • Impact of health, treatment and psychological factors on cognitive functioning after chemotherapy for early breast cancer

    Open Access•Katharine Vearncombe, Katharine Jean Vearncombe et al.•Australian Psychologist•2009

  • A New Depression Scale Designed to be Sensitive to Change

    Open Access•Stuart A Montgomery, Stuart Montgomery et al.•The British Journal of Psychiatry•1979

  • X. On the criterion that a given system of deviations from the probable in the case of a correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling

    Karl Pearson•The London, Edinburgh, and Dublin…•1900

  • Selective effects of minor illnesses on human performance

    Open Access•Andrew P Smith, D A J Tyrrell et al.•British Journal of Psychology•1987

Unique citing works3
Citations per year0.18
Citation span2009 - 2023 (15)
Citation velocityhistorical
Highly citedNo
Citation typesNeutral: 3

Tools

Open DOISci-Hub
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae